Medications for Bingeeating Disorder

13 results

  • lisdexamfetamine dimesylate

    (LISDEXAMFETAMINE DIMESYLATE)
    Sun Pharmaceutical Industries, Inc.
    Lisdexamfetamine dimesylate is indicated for treating Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 and older and for moderate to severe binge eating disorder (BED) in adults. It is not recommended for weight loss or in children under 6 due to potential risks.

  • lisdexamfetamine dimesylate

    (LISDEXAMFETAMINE DIMESYLATE)
    Rhodes Pharmaceuticals
    Lisdexamfetamine Dimesylate Capsules are indicated for treating Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 and older and moderate to severe binge eating disorder (BED) in adults. Limitations include its unsuitability for weight loss and potential risks in younger pediatric patients.

  • lisdexamfetamine dimesylate

    (LISDEXAMFETAMINE DIMESYLATE)
    Granules Pharmaceuticals Inc.
    Lisdexamfetamine dimesylate capsules are indicated for treating Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 and older and moderate to severe binge eating disorder (BED) in adults. They are not recommended for weight loss or for pediatric patients under 6 years due to potential risks.

  • lisdexamfetamine dimesylate

    (LISDEXAMFETAMINE DIMESYLATE)
    Bryant Ranch Prepack
    Lisdexamfetamine Dimesylate Capsules are indicated for treating Attention Deficit Hyperactivity Disorder (ADHD) in adults and children aged 6 and older, and for moderate to severe binge eating disorder (BED) in adults. It is not indicated for weight loss.

  • lisdexamfetamine dimesylate

    (lisdexamfetamine dimesylate)
    Alvogen Inc.
    Lisdexamfetamine dimesylate capsules are indicated for treating Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 and older and moderate to severe binge eating disorder (BED) in adults. It is not recommended for weight loss due to associated cardiovascular risks and lack of established safety.

  • lisdexamfetamine dimesylate

    (LISDEXAMFETAMINE DIMESYLATE)
    Bryant Ranch Prepack
    Lisdexamfetamine Dimesylate Capsules are indicated for treating Attention Deficit Hyperactivity Disorder (ADHD) in individuals aged 6 and older and for moderate to severe binge eating disorder (BED) in adults. It is not approved for weight loss due to associated cardiovascular risks.

  • lisdexamfetamine dimesylate

    (LISDEXAMFETAMINE DIMESYLATE)
    Bryant Ranch Prepack
    Lisdexamfetamine Dimesylate Capsules are indicated for treating Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 and older, and moderate to severe binge eating disorder (BED) in adults. The drug is not approved for weight loss due to potential cardiovascular risks.

  • lisdexamfetamine dimesylate

    (LISDEXAMFETAMINE DIMESYLATE)
    Bryant Ranch Prepack
    Lisdexamfetamine Dimesylate Capsules are indicated for treating Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older and moderate to severe binge eating disorder in adults. It is not recommended for weight loss or in pediatric patients under 6 due to potential risks.

  • lisdexamfetamine dimesylate

    (LISDEXAMFETAMINE DIMESYLATE)
    Bryant Ranch Prepack
    Lisdexamfetamine Dimesylate Capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 and older and for moderate to severe binge eating disorder (BED) in adults. The drug is not recommended for weight loss and lacks established efficacy for obesity.

  • lisdexamfetamine dimesylate

    (Lisdexamfetamine Dimesylate)
    Lannett Company, Inc.
    Lisdexamfetamine dimesylate capsules are indicated for treating Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 and older and for moderate to severe binge eating disorder (BED) in adults. It is not approved for weight loss.